Oxford Medicaid COVID-19 service claims reached at least $19,424 in 2024

At least $19,424 in Medicaid payments in Oxford during 2024 were made for services billed using HCPCS codes specifically designated for COVID-19, according to data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, a public health insurance initiative managed by states with joint federal and state funding, provides coverage for low-income individuals and families, seniors, children, and people with disabilities, making it a major component of the U.S. health care system.

Since Medicaid is funded by taxpayers, fluctuations in local billing levels reflect changes in community allocation of public health care resources.

For this report, COVID-19–related services were determined through HCPCS codes marked as “COVID-19” or “coronavirus”-related within billing descriptions or other reference documentation. These figures only include services explicitly labeled as COVID-related in billing records, excluding pandemic-related care under more general or differently categorized medical codes.

By comparison, Charlotte had the highest Medicaid payments for COVID-19 services in North Carolina for 2024, with claims totaling $2,373,883 for virus-related services.

In Oxford, three providers filed Medicaid claims for COVID-19–related services in 2024. The Immunoassay code was the most frequently billed, representing $18,766 of the total.

The average Medicaid payment per provider in Oxford for COVID-19–related services was $6,475, which is less than the North Carolina average of $37,126 per provider.

During the pandemic years, spending on COVID-19–specific services contributed noticeably to increases in Oxford’s total Medicaid spending.

Across all other claim types, overall Medicaid payments rose by $5,358,565 from 2020 to 2024, a 56.8% increase.

In the two-year span prior to the pandemic, Oxford’s average annual Medicaid payments were $8,346,602.

According to the Centers for Medicare & Medicaid Services, federal and state Medicaid spending combined reached approximately $871.7 billion in fiscal 2023, about 18% of total U.S. health expenditures—an increase from roughly $613.5 billion in 2019, before the COVID-19 pandemic.

This growth amounts to an increase of about 40% in just a few years, largely due to enrollment increases and greater service use during and after the pandemic.

Recent federal budget legislation under the Trump administration has featured major proposals to shrink federal Medicaid funding and reorganize the program. The “One Big Beautiful Bill Act,” passed in 2025, is expected to lower federal Medicaid expenditures by more than $1 trillion over the next 10 years and institute changes such as work requirements and more cost-sharing. This is projected to move additional costs to states and slow the growth of federal Medicaid support, even as coverage continues for tens of millions of Americans.

Note: Includes only HCPCS codes explicitly labeled for COVID-19 services; totals do not encompass all pandemic-related health care expenditures.

Information in this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Access the source data here.